Francois Nader, President, CEO and Director at NPS PHARMACEUTICALS INC (NPSP), sold 448,367 shares at $11.01 ($5.1M) on 2013-04-08, disclosed to the SEC on 2013-04-10.
Scheduled sale ($5.1M) by President, CEO and Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.01 | 150,000 | $1.7M | 32.5% |
| 2 | $11.27 | 150,000 | $1.7M | 33.3% |
| 3 | $11.68 | 148,367 | $1.7M | 34.1% |
| Total | $11.32 avg | 448,367 | $5.1M | 100% |
| Filing → |
| NPSP | SELL | 2013-09-30 | $6.4M | — | Filing → |
| NPSP | BUY | 2011-11-10 | $161K | — | Filing → |
| NPSP | SELL | 2010-04-02 | $65K | — | Filing → |